San Diego, CA
The Center, part of a national proton therapy network, struggled to achieve expected utilization and operated for years without reaching break-even cash flow, ultimately filing for bankruptcy with significant debt.
Carl Marks Advisors (CMA) served as Chief Restructuring Officer, overseeing financial and operational restructuring, day-to-day management, and the eventual sale of the Center to senior lenders through a 363 sale. CMA managed non-medical operations, interfacing with key stakeholders, including physicians, IT, maintenance, and equipment vendors, while ensuring the financial and operational data supported both management and the sale process.